Cargando…

An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma

The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Crevar-Sakač, Milkica, Vujić, Zorica, Brborić, Jasmina, Kuntić, Vesna, Uskoković-Marković, Snežana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270013/
https://www.ncbi.nlm.nih.gov/pubmed/23439563
http://dx.doi.org/10.3390/molecules18032469
_version_ 1783376600366055424
author Crevar-Sakač, Milkica
Vujić, Zorica
Brborić, Jasmina
Kuntić, Vesna
Uskoković-Marković, Snežana
author_facet Crevar-Sakač, Milkica
Vujić, Zorica
Brborić, Jasmina
Kuntić, Vesna
Uskoković-Marković, Snežana
author_sort Crevar-Sakač, Milkica
collection PubMed
description The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The purpose of a screening design is to identify the factors that have significant effects on the selected chromatographic responses, and for this purpose a full 2(3) factorial design was used. The location of the true optimum was established by applying Derringer’s desirability function, which provides simultaneously optimization of all seven responses. The ranges of the independent variables used for the optimization were content of acetonitrile in mobile phase (60–70%), temperature of column (30–40 °C) and flow rate (0.8–1.2 mL min(−1)). The influences of these independent variables were evaluated for the output responses: retention time of first peak (p-hydroxyatorvastatin) and of last peak (atorvastatin, lactone form), symmetries of all four peaks and relative retention time of p-hydroxyatorvastatin. The primary goal of this investigation was establishing a new simple and sensitive method that could be used in analysis of biological samples. The method was validated and successfully applied for determination of atorvastatin (acid and lactone forms) and its metabolites in plasma.
format Online
Article
Text
id pubmed-6270013
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62700132018-12-20 An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma Crevar-Sakač, Milkica Vujić, Zorica Brborić, Jasmina Kuntić, Vesna Uskoković-Marković, Snežana Molecules Article The aim of the present study was to optimize a chromatographic method for the analysis of atorvastatin (acid and lactone forms), ortho- and para-hydroxyatorvastatin by using an experimental design approach. Optimization experiments were conducted through a process of screening and optimization. The purpose of a screening design is to identify the factors that have significant effects on the selected chromatographic responses, and for this purpose a full 2(3) factorial design was used. The location of the true optimum was established by applying Derringer’s desirability function, which provides simultaneously optimization of all seven responses. The ranges of the independent variables used for the optimization were content of acetonitrile in mobile phase (60–70%), temperature of column (30–40 °C) and flow rate (0.8–1.2 mL min(−1)). The influences of these independent variables were evaluated for the output responses: retention time of first peak (p-hydroxyatorvastatin) and of last peak (atorvastatin, lactone form), symmetries of all four peaks and relative retention time of p-hydroxyatorvastatin. The primary goal of this investigation was establishing a new simple and sensitive method that could be used in analysis of biological samples. The method was validated and successfully applied for determination of atorvastatin (acid and lactone forms) and its metabolites in plasma. MDPI 2013-02-25 /pmc/articles/PMC6270013/ /pubmed/23439563 http://dx.doi.org/10.3390/molecules18032469 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Crevar-Sakač, Milkica
Vujić, Zorica
Brborić, Jasmina
Kuntić, Vesna
Uskoković-Marković, Snežana
An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title_full An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title_fullStr An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title_full_unstemmed An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title_short An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma
title_sort improved hplc method with the aid of a chemometric protocol: simultaneous determination of atorvastatin and its metabolites in plasma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270013/
https://www.ncbi.nlm.nih.gov/pubmed/23439563
http://dx.doi.org/10.3390/molecules18032469
work_keys_str_mv AT crevarsakacmilkica animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT vujiczorica animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT brboricjasmina animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT kunticvesna animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT uskokovicmarkovicsnezana animprovedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT crevarsakacmilkica improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT vujiczorica improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT brboricjasmina improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT kunticvesna improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma
AT uskokovicmarkovicsnezana improvedhplcmethodwiththeaidofachemometricprotocolsimultaneousdeterminationofatorvastatinanditsmetabolitesinplasma